These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10192403)

  • 1. An overview of the treatment of schizoaffective disorder.
    McElroy SL; Keck PE; Strakowski SM
    J Clin Psychiatry; 1999; 60 Suppl 5():16-21; discussion 22. PubMed ID: 10192403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in the pharmacologic treatment of schizoaffective disorder.
    Keck PE; McElroy SL; Strakowski SM
    J Clin Psychiatry; 1996; 57 Suppl 9():41-8. PubMed ID: 8823349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing an individualized treatment plan for patients with schizoaffective disorder: from pharmacotherapy to psychoeducation.
    Vieta E
    J Clin Psychiatry; 2010; 71 Suppl 2():14-9. PubMed ID: 21190648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Consensus Group on Bipolar I Depression Treatment Guidelines.
    Calabrese JR; Kasper S; Johnson G; Tajima O; Vieta E; Yatham LN; Young AH
    J Clin Psychiatry; 2004 Apr; 65(4):571-9. PubMed ID: 15119923
    [No Abstract]   [Full Text] [Related]  

  • 5. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V; Libov I; Kotler M; Strous RD
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects.
    Wright G; Galloway L; Kim J; Dalton M; Miller L; Stern W
    J Clin Psychiatry; 1985 Jan; 46(1):22-5. PubMed ID: 2856918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What we know and what we don't know about the treatment of schizoaffective disorder.
    Murru A; Pacchiarotti I; Nivoli AM; Grande I; Colom F; Vieta E
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):680-90. PubMed ID: 21565468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bipolar disorder.
    Möller HJ; Nasrallah HA
    J Clin Psychiatry; 2003; 64 Suppl 6():9-17; discussion 28. PubMed ID: 12720475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of schizoaffective disorder and schizophrenia with mood symptoms.
    Levinson DF; Umapathy C; Musthaq M
    Am J Psychiatry; 1999 Aug; 156(8):1138-48. PubMed ID: 10450252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consensus guidelines outline drug selection and sequencing options for bipolar disorder.
    Rep Med Guidel Outcomes Res; 2000 May; 11(10):1-2, 5. PubMed ID: 11770548
    [No Abstract]   [Full Text] [Related]  

  • 13. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment of patients hospitalized with the diagnosis of schizoaffective disorder.
    Grieger TA; Benedek DM; Flynn J
    J Clin Psychiatry; 2001 Jan; 62(1):59-60. PubMed ID: 11235933
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment guidelines for non-schizophrenic psychotic disorders?].
    Jäger M; Frasch K; Weinmann S; Becker T
    Psychiatr Prax; 2007 Nov; 34(8):370-6. PubMed ID: 17806003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emergency treatment of depression complicated by psychosis or agitation.
    Glick RL; Ghaemi SN
    J Clin Psychiatry; 2000; 61 Suppl 14():43-8. PubMed ID: 11154016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine treatment of major depressive episodes in the course of psychotic disorders.
    Zink M; Knopf U; Mase E; Kuwilsky A; Deuschle M
    Pharmacopsychiatry; 2006 May; 39(3):109-11. PubMed ID: 16721699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium combinations in acute and maintenance treatment of unipolar and bipolar depression.
    Fawcett JA
    J Clin Psychiatry; 2003; 64 Suppl 5():32-7. PubMed ID: 12720482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.